AACR - PDFSEARCH.IO - Document Search Engine

AACR
Results: 360

#	Item
71	October 14, 2013 Astex Pharmaceuticals to Present at AACR-NCI-EORTC DUBLIN, Calif., Oct. 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc., a pharmaceutical company dedicated to the discovery and development of n Add to Reading List Source URL: astx.com Language: English
72	Astex Pharmaceuticals to Present at AACR Annual Meeting DUBLIN, Calif., March 29, [removed]Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small mole Add to Reading List Source URL: astx.com Language: English Astex Protein kinase inhibitors Drug discovery Aurora inhibitor Pharmaceutical sciences Pharmacology Biology
73	Astex To Present Data From Its FGFR Inhibitor Programme at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 Cambridge, UK, 29th March[removed]Astex Therapeutics, the UK-based biotechnology comp Add to Reading List Source URL: astx.com Language: English Pharmacology Clinical research Medicinal chemistry Astex Fibroblast growth factor receptor 1 Fibroblast growth factor receptor Tyrosine kinase Fibroblast growth factor Protein kinase Pharmaceutical sciences Biology Tyrosine kinase receptors
74	Abstract 928 AACR 2012 The novel clinical candidate AT13148 is an oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity and a mechanism of action distinct from AKT inhibitors Add to Reading List Source URL: astx.com Language: English Oncology Phosphoinositide 3-kinase AKT PTEN HER2/neu Breast cancer Akt/PKB signaling pathway Phosphoinositide-dependent kinase-1 Medicine Biology Protein kinases
75	Microsoft PowerPoint - JM AACR 2014_SGI110 Add to Reading List Source URL: astx.com Language: English - Date: 2014-06-09 09:31:13 Alkylating antineoplastic agents Ammine complexes Cisplatin Carboplatin DNA methylation Methylation Gene expression Chemistry Genetics Epigenetics
76	Microsoft PowerPoint - 2014_SGI-110_Poster_AACR_abst_2321_Oganesian_final-print Add to Reading List Source URL: astx.com Language: English - Date: 2014-06-09 09:38:33 Stem cells Bone marrow Circulatory system Lymphatic system Skeletal system Hypomethylating agent Polonium Bone Anatomy Matter Biology
77	Microsoft PowerPoint[removed]AACR. Fleming et al. Clinical epigenetic resensitization of platinum-rsistant (SGI-110) Add to Reading List Source URL: astx.com Language: English - Date: 2014-06-09 09:35:32 Eli Lilly and Company Organofluorides Carboplatin Gemcitabine Ovarian cancer Hypomethylating agent Chemistry Alkylating antineoplastic agents Ammine complexes
78	ANNUAL AUDIT COMPLIANCE REPORT PROFORMA FOR A LICENCE ISSUED UNDER PART V OF THE ENVIRONMENTAL PROTECTION ACT[removed]An Annual Audit Compliance Report (AACR) is a mechanism for industry licence holders to report on their Add to Reading List Source URL: www.der.wa.gov.au Language: English - Date: 2013-10-02 01:07:32 Auditing United States corporate law United States securities law SEC filings Business Finance Regulatory compliance Audit Corporate governance
79	Integrative Molecular Cancer Epidemiology An IARC-EACR-AACR-ECNIS Symposium 3-5 July 2008 http://www.iarc.fr/molepi2008 International Congress Center of Lyon Add to Reading List Source URL: www.iarc.fr Language: English - Date: 2012-04-27 07:13:22 Oncology Paolo Boffetta Molecular epidemiology Cancer research Cancer Medicine Health Epidemiology
80	Kolltan Cancer Study Results for KTN3379, Targeting ErbB3, Support Evaluating Combinations with Targeted Therapies Phase 1 Clinical Data and Crystallographic Data will be Presented at AACR/EORTC/NCI November Meeting NEW Add to Reading List Source URL: hbmpartners.com Language: English - Date: 2014-09-16 06:14:04 Epidermal growth factor receptor ERBB3 Tyrosine kinase ErbB Targeted therapy Tyrosine kinase receptors Oncogenes Biology

UPDATE